To celebrate World Amyloidosis Day on October 26 the AAN is offering separate virtual education programs for Patients and Families and Doctors and Health Professionals.

These sessions are scheduled for:

• Patients and Families – Saturday October 26, 1pm
• Doctors and Health Professionals – Thursday October 31, 4pm

The registration form will be accessible on this page from October 14 through to October 24.

Virtual Patient, Family & Carer Event – Saturday, October 26 – PROGRAM

Bios:

Dr Kah Peck is a clinical cardiologist and cardiac imaging specialist with a special interest in cardiac amyloidosis. Dr Peck graduated from Monash University with honours and was awarded the Harriet Power Prize in Medicine and the Southern Clinical School Awards for Excellence. He completed his cardiology training through Eastern Health, Peninsula Health and Monash Health. His contribution to research was recognised with three prizes from Cardiac Society of Australia and New Zealand (CSANZ) and Eastern Health. After being awarded his FRACP, he went on to complete an Advanced Echocardiography and Cardiac CT fellowship at Monash Health, followed by a Cardiac MRI fellowship at Alfred Health. Dr Peck is a consultant cardiologist at Eastern Health, Epworth Eastern, Knox Private Hospital and a clinical research fellow at Baker Heart and Diabetes Institute. He is the inaugural cardiologist of the Victorian and Tasmanian Amyloidosis Service (VTAS) providing expert opinion on the investigation, management and imaging of patients with cardiac amyloidosis.  Dr Peck is the principal investigator of several clinical trials investigating novel therapies in the treatment of ATTR cardiac amyloidosis.

Dr Lisa Paxton is a nephrologist who underwent her medical training at Monash University, graduating with honors. She completed her basic training through the Royal Melbourne Hospital and has subsequently specialised in Nephrology through Eastern Health, The Royal Melbourne Hospital and Bendigo Health. Dr Paxton’s interest in amyloidosis started during her nephrology training  through Eastern Health due to her exposure to the Victorian and Tasmanian Amyloidosis Service (VTAS).  She is currently undertaking an Amyloidosis fellowship at Eastern Health where she is gaining skills in the holistic management of the condition and the many systems it affects.
Dr Paxton hopes to continue seeing amyloidosis patients as she transitions to work as an early consultant, and is interested in newer therapies and clinical trials.

Dr Olga Motorna is a clinical haematologist and Myeloma Lead in Box Hill Hospital and an Acting Director of the Victorian and Tasmanian Amyloidosis Service (VTAS). She obtained Bachelor of Science in Biology from Hope College in Michigan, and following a year of basic science research at the Van Andel Cancer Research Institute, she moved to Ireland where she completed her medical studies at Trinity College Dublin. She relocated to Melbourne in 2012 and underwent her physician training and haematology advanced training at Monash Health and the Alfred Hospital. She is currently finishing her PhD studies at the Peter MacCallum Cancer Centre where she is elucidating mechanisms of epigenetic regulation in multiple myeloma. She is a recipient of NHMRC Scholarship and HSANZ New Investigator Scholarship. She is passionate about patient-centered care and bringing clinical trials to patients with myeloma and amyloidosis to improve their access to most effective therapy. She is a principal investigator on numerous trials currently open at Box Hill Hospital.